Tagreed Alkaltham: Preventing the Risk of Transfusion Reactions Before They Occur
Tagreed Alkaltham, Transfusion Medicine Lab Supervisor at KSMC, shared a post on LinkedIn:
“Preventing Transfusion Reactions
How Do We Reduce the Risk Before It Happens?
Engineering Safety in Transfusion Medicine
After discussing recognition and post-transfusion work-up,
a more important question emerges:
How do we reduce the likelihood of a reaction before it ever happens?
In transfusion medicine, safety is not a response.
It is a system.
Prevention Begins Before Issue:
Risk reduction starts long before blood reaches the bedside:
- Accurate patient identification
- Proper antibody screening and history review
- Reviewing previous transfusion reactions
- Selecting special requirements when indicated (irradiated, etc.)
Many severe reactions are preventable at this stage.
Product Integrity Matters:
A strong system protects through:
- Proper storage and temperature monitoring
- Visual inspection before release
- Bacterial risk mitigation strategies
- Clear documentation and traceability
Safety is consistency, not luck.
The Bedside Is the Final Safety Layer:
- Independent identity verification
- Baseline vital signs
- Controlled initial infusion rate
- Early recognition of subtle symptoms
The first minutes matter, but they should not be the only defense.
Governance Makes Prevention Sustainable:
- Reaction audits
- Near-miss reporting
- Trend analysis
- Education feedback loops
Prevention is data-driven.
It is measured.
It is continuously refined.
Transfusion reactions are clinical events.
Prevention is a leadership decision.
Safety in transfusion medicine is not built in crisis
it is engineered long before the first drop flows”
Stay updated with Hemostasis Today.
-
Apr 16, 2026, 09:41Wolfgang Miesbach: Adeno-Associated Virus Neutralizing Antibodies and Their Clinical Impact on Gene Therapy
-
Apr 16, 2026, 09:33Jeyaraj Pandian: Low-Cost Stroke Rehabilitation Technologies at MENA-VINM 2026
-
Apr 16, 2026, 09:21Aurore Ughetto: The Hemocompatibility Burden of Micro-Axial Flow Pump Support
-
Apr 16, 2026, 09:09Naung Latt Htun: High Clinical Suspicion in Acquired Hemophilia A is Essential
-
Apr 16, 2026, 08:58Chittal Raulji: ASH-ISTH 2026 Guidelines for Anticoagulant Prophylaxis for Pediatric VTE Is Now Live in Blood Advances
-
Apr 16, 2026, 08:47Wolfgang Miesbach: Key Open Questions and Clinical Paradoxes in ITP
-
Apr 16, 2026, 08:19M Rafiqul Islam: Post-Thrombectomy Blood Pressure Management in Acute Ischemic Stroke
-
Apr 16, 2026, 06:58Rob Maloney: From Past to Progress in Hemophilia Care in the Dominican Republic
-
Apr 16, 2026, 06:51Michael Ertl: Patient-Reported Outcomes Reveal Differences in Perceived Stroke Recovery